Disease/Infection News

RSS

'Details of implementation' critical to reaching goal of AIDS-free generation

Noting the progress made since the beginning of the HIV/AIDS epidemic and the upcoming recognition of World AIDS Day on December 1, Ronald Valdiserri, deputy assistant secretary for health, infectious diseases at the Department of Health and Human Services, writes in a Public Health Reports opinion piece, "We would do well to keep in mind the following caution. No matter the elegance of the controlled trial, the statistical significance of the results, or the superiority of the science, we must confront this inevitable reality: We will never be able to take full advantage of our progress in HIV clinical and prevention science until we develop and sustain the human, organizational, and structural capacities necessary to implement these new scientific breakthroughs."

3 Nov 2012

'Keep the Promise on HIV/AIDS' March and Rally to be held on Nov. 3 in Centennial Park

Hundreds of advocates and community leaders are expected to participate in the "Keep the Promise on HIV/AIDS" March and Rally this Saturday, November 3, 2012 beginning at 1:00 pm in Centennial Park.

3 Nov 2012

Weill Cornell researchers awarded Grand Challenges Explorations grants

Weill Cornell Medical College announced today that it is a Grand Challenges Explorations winner, an initiative funded by the Bill & Melinda Gates Foundation.

3 Nov 2012

ACE Environmental Advisory explores potential risks of mold and legionella at healthcare facilities

The ACE Group today announced the release of an environmental advisory entitled, "Legionella and Mold: Construction and Renovation Risks at Healthcare Facilities," which explores the potential risks of pollutants, such as mold and legionella, that hospitals and healthcare facilities can experience during renovation or construction projects.

3 Nov 2012

GlobalPost interviews director of WHO Stop TB Department about future of global response

In an interview with GlobalPost's "Global Pulse" blog, Mario Raviglione, director of the WHO's Stop TB Department, explains "why the fight against [tuberculosis (TB)] is at a crossroads."

3 Nov 2012

Xenex offers room disinfection devices to hospitals hit by Hurricane Sandy

Xenex Healthcare Services, the world leader in UV room disinfection systems, today announced it is making its room disinfection devices available to hospitals affected by Hurricane Sandy.

3 Nov 2012

WSU researcher receives NSF fund to study on antibiotic resistance

In March, the director-general of the World Health Organization warned of "an end to modern medicine as we know it."

3 Nov 2012

Asia-Pacific accounts for second highest burden of malaria outside of Africa, RBM Partnership report says

At a meeting of leading malaria scientists, political leaders, and health experts in Sydney on Friday, the Roll Back Malaria Partnership released a new report (.pdf) showing that more than two billion people in the Asia-Pacific region are at risk of the disease, Agence France-Presse reports.

3 Nov 2012

NCAR launches study into impact of open-fire cooking on regional air quality and disease

Expanding its focus on the link between the atmosphere and human health, the National Center for Atmospheric Research (NCAR) is launching a three-year, international study into the impact of open-fire cooking on regional air quality and disease.

3 Nov 2012

Intensified antibiotic treatment can improve prognosis of patients with TB meningitis

Researchers from the Radboud UMC have conducted the first study globally to show that intensified antibiotic treatment can improve the prognosis of patients with tuberculous (TB) meningitis, the most severe form of TB which carries a mortality of up to 50%.

3 Nov 2012

Mass spectrometry can help visualize how drugs work inside living cells to kill infectious microbes

Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside living cells to kill infectious microbes.

3 Nov 2012

Resolve to fight TB must be strengthened in U.S. global AIDS blueprint

As part of its "Blueprint" series discussing the creation of a U.S. global AIDS blueprint called for by Secretary of State Hillary Clinton in July, the Center for Global Health Policy's "Science Speaks" blog features an opinion piece by Salmaan Keshavjee of Harvard Medical School and Partners In Health. With an estimated 1,000 people with HIV dying of tuberculosis (TB) every day, "it is clear that our current approaches to addressing the global tuberculosis pandemic are inadequate," he writes.

3 Nov 2012

Phase II study to evaluate Medivir/Janssen's simeprevir and Vertex against HCV

Medivir AB, announced today plans for a phase II proof-of-concept study of an all-oral regimen for the treatment of hepatitis C containing of Medivir/Janssen's protease inhibitor simeprevir and Vertex's nucleotide analogue hepatitis C virus (HCV) polymerase inhibitor VX-135.

3 Nov 2012

Health experts gather in Sydney for 3-day malaria conference

"More than 200 health experts have gathered in Sydney for a three-day conference to bolster political commitment to tackle the spread of malaria," IRIN reports.

3 Nov 2012

Compounding pharmacies rarely get tough punishments; Another firm recalls drugs

USA Today examines how officials have dealt with charges of misconduct at the pharmacies in the past. Meanwhile, a compounding pharmacy, which is owned by the same company that owned the plant linked to the meningitis outbreak, is recalling its products after an FDA review.

2 Nov 2012

Afghanistan, U.N. agencies working to improve routine immunization as winter approaches

"Afghanistan is taking steps to improve its routine immunization coverage, after a drop in coverage led to a sharp increase in measles outbreaks last year, killing more than 300 children," IRIN reports.

2 Nov 2012

Janssen, Vertex to evaluate TMC435 and VX-135 in Phase 2 HCV study

Janssen Pharmaceuticals, Inc. today announced that it has entered into a non-exclusive collaboration with Vertex Pharmaceuticals Incorporated to evaluate in a Phase 2 study the safety and efficacy of an all-oral regimen for the treatment of hepatitis C (HCV).

2 Nov 2012

New data: 4 in 5 children received recommended doses of DTP vaccine during infancy in 2011

Four in five children (83%) worldwide received the recommended three doses of diphtheria-tetanus-pertussis (DTP) vaccine during infancy in 2011, according to new data released in the Morbidity and Mortality Weekly Report and in the WHO Weekly Epidemiological Record (WER).

2 Nov 2012

Malarial drug shows promise in stopping breast cancer

A malarial drug is showing promise in stopping breast cancer before it starts, Mason researchers are discovering during a clinical trial.

2 Nov 2012

Multiple sclerosis disease activity reduced by leukaemia drug, even when first-line treatment has failed

A drug which was originally developed to treat leukaemia and other cancers of the immune system offers substantial improvements over existing treatments in reducing relapse rates for people with multiple sclerosis (MS), even when they have not responded well to first-line treatment, according to the results of two phase 3 trials published Online First in The Lancet.

1 Nov 2012

Disease/Infection News

'Details of implementation' critical to reaching goal of AIDS-free generation

'Keep the Promise on HIV/AIDS' March and Rally to be held on Nov. 3 in Centennial Park

Weill Cornell researchers awarded Grand Challenges Explorations grants

ACE Environmental Advisory explores potential risks of mold and legionella at healthcare facilities

GlobalPost interviews director of WHO Stop TB Department about future of global response

Xenex offers room disinfection devices to hospitals hit by Hurricane Sandy

WSU researcher receives NSF fund to study on antibiotic resistance

Asia-Pacific accounts for second highest burden of malaria outside of Africa, RBM Partnership report says

NCAR launches study into impact of open-fire cooking on regional air quality and disease

Intensified antibiotic treatment can improve prognosis of patients with TB meningitis

Mass spectrometry can help visualize how drugs work inside living cells to kill infectious microbes

Resolve to fight TB must be strengthened in U.S. global AIDS blueprint

Phase II study to evaluate Medivir/Janssen's simeprevir and Vertex against HCV

Health experts gather in Sydney for 3-day malaria conference

Compounding pharmacies rarely get tough punishments; Another firm recalls drugs

Afghanistan, U.N. agencies working to improve routine immunization as winter approaches

Janssen, Vertex to evaluate TMC435 and VX-135 in Phase 2 HCV study

New data: 4 in 5 children received recommended doses of DTP vaccine during infancy in 2011

Malarial drug shows promise in stopping breast cancer

Multiple sclerosis disease activity reduced by leukaemia drug, even when first-line treatment has failed

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News